[(18)F]FDG and [(18)F]NaF as PET markers of systemic atherosclerosis progression: A longitudinal descriptive imaging study in patients with type 2 diabetes mellitus.
[(18)F]FDG and [(18)F]NaF as PET markers of systemic atherosclerosis progression: A longitudinal descriptive imaging study in patients with type 2 diabetes mellitus.
复制标题
DOI:
10.1007/s12350-021-02781-w
复制
发表时间:
2022-08
期刊:
影响因子:
--
通讯作者:
中科院分区:
文献类型:
--
作者:
While [18F]-fluordeoxyglucose ([18F]FDG) uptake is associated with arterial inflammation, [18F]-sodium fluoride ([18F]NaF) is a marker for arterial micro-calcification. We aimed to investigate the prospective correlation between both PET markers over time and whether they are prospectively ([18F]FDG) and retrospectively ([18F]NaF) related to progression of systemic arterial disease in a longitudinal study in patients with type 2 diabetes mellitus (T2DM). Baseline [18F]FDG PET/Low Dose (LD) Computed Tomography (CT) scans of ten patients with early T2DM without cardiovascular history (70% men, median age 63 years) were compared with five-year follow-up [18F]NaF/LDCT scans. Systemic activity was expressed as mean target-to-background ratio (meanTBR) by dividing the maximal standardized uptake value (SUVmax) of ten arteries by SUVmean of the caval vein. CT-assessed macro-calcifications were scored visually and expressed as calcified plaque (CP) score. Arterial stiffness was assessed with carotid-femoral pulse wave velocity (PWV). Five-year changes were expressed absolutely with delta (Δ) and relatively with %change. Baseline meanTBR[18F]FDG was strongly correlated with five-year follow-up meanTBR[18F]NaF (r = 0.709, P = .022). meanTBR[18F]NaF correlated positively with ΔCPscore, CPscore at baseline, and follow-up (r = 0.845, P = .002 and r = 0.855, P = .002, respectively), but not with %change in CPscore and PWV. This proof-of-concept study demonstrated that systemic arterial inflammation is an important pathogenetic factor in systemic arterial micro-calcification development. The online version contains supplementary material available at 10.1007/s12350-021-02781-w.
登录
查看更多内容
影响因子:
10.8
作者:
Durham AL;Speer MY;Scatena M;Giachelli CM;Shanahan CM
通讯作者:
Shanahan CM
DOI:
10.1007/s10554-015-0739-2
发表时间:
2016-01
期刊:
The international journal of cardiovascular imaging
影响因子:
--
作者:
Liu J;Kerwin WS;Caldwell JH;Ferguson MS;Hippe DS;Alessio AM;Martinez-Malo V;Pimentel K;Miyaoka RS;Kohler TR;Hatsukami TS;Yuan C
通讯作者:
Yuan C
DOI:
10.1007/s00259-018-4078-0
发表时间:
2018-11
影响因子:
9.1
作者:
McKenney-Drake ML;Moghbel MC;Paydary K;Alloosh M;Houshmand S;Moe S;Salavati A;Sturek JM;Territo PR;Weaver C;Werner TJ;Høilund-Carlsen PF;Sturek M;Alavi A
通讯作者:
Alavi A
DOI:
10.1007/s12350-018-1325-5
发表时间:
2019-08
期刊:
Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology
影响因子:
--
作者:
Hop H;de Boer SA;Reijrink M;Kamphuisen PW;de Borst MH;Pol RA;Zeebregts CJ;Hillebrands JL;Slart RHJA;Boersma HH;Doorduin J;Mulder DJ
通讯作者:
Mulder DJ
DOI:
10.1007/s12350-020-02458-w
发表时间:
2022-06
期刊:
Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology
影响因子:
--
作者:
Fletcher AJ;Lembo M;Kwiecinski J;Syed MBJ;Nash J;Tzolos E;Bing R;Cadet S;MacNaught G;van Beek EJR;Moss AJ;Doris MK;Walker NL;Dey D;Adamson PD;Newby DE;Slomka PJ;Dweck MR
通讯作者:
Dweck MR